Clinical trial No longer in our active list Interventional Ages 18 and up

Exploring therapy options for post-COVID-19 syndrome

Official title: Randomized Comparison of a Telemedicine-supported Psychosomatic Intervention, a Physical Activity Intervention and the Combination of Both in Patients with Post-covid19 Syndrom.

Run by Hannover Medical School · NCT06042751 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether psychotherapy, physical rehab, or a mix of both can help reduce fatigue in people dealing with post-COVID-19 syndrome.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment195 (estimated)
SponsorHannover Medical School
Academic / other
Locations1 site (Hannover, Lower Saxony)
Trial IDNCT06042751 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 diagnosed with post-COVID-19 syndrome and experiencing significant fatigue.

Probably not a fit

Patients with severe mental illness or other conditions that could explain their fatigue symptoms may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of psychotherapy, physical rehabilitation, and a combination of both on fatigue in patients suffering from post-COVID-19 syndrome. Participants will be randomly assigned to one of three intervention groups and will receive therapeutic online sessions for 50 minutes every two weeks over a three-month period. The study aims to evaluate how these interventions impact fatigue levels and exercise capacity, with a follow-up period to assess sustainability of the benefits. The trial will also consider factors such as sex, gender, and BMI in the assignment of participants to ensure balanced groups.

Why it matters

Potential benefit: If successful, this study could provide tailored therapeutic options for improving fatigue in post-COVID-19 patients.

How similar studies have gone: While there is limited research specifically on the combination of these therapies for post-COVID-19 syndrome, similar approaches have shown promise in other fatigue-related conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged over 18 and
* diagnosed post-Covid-19 syndrome: (positive PCR or antibody test) and Fatigue Assessment Scale (FAS) ≥ 22 points

Exclusion Criteria:

* Current participation in another intervention study
* Illnesses or functional disorders that potentially explain the fatigue symptoms otherwise
* Any illness or impairment that the examining physician judges to preclude participation in a physical training intervention
* Suicidality or severe mental illness (e.g. mania, acute phase of schizophrenia) that requires acute treatment.

Where it's running

  • Hannover Medical School
    Hannover, Lower Saxony, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.